These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 191387)

  • 21. Genital herpes virus findings in relation to cervical neoplasia.
    Royston I; Aurelian L; Davis HJ
    J Reprod Med; 1970 Apr; 4(4):9-13. PubMed ID: 4328889
    [No Abstract]   [Full Text] [Related]  

  • 22. Sero-immunological investigations in patients with cervical cancer: higher rate of HSV-2 antibodies than in syphilis patients and evidence of IgM antibodies to an early HSV-1 antigen.
    Schneweis KE; Haag A; Lehmköster A; Koenig U
    IARC Sci Publ (1971); 1975; (11 Pt 2):53-7. PubMed ID: 191383
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
    Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
    Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 25. Isoantigens ABO in cervical neoplasia.
    Stafl A; Mattingly RF
    Gynecol Oncol; 1972 Nov; 1(1):26-35. PubMed ID: 4669441
    [No Abstract]   [Full Text] [Related]  

  • 26. Antigenic deletion in cervical neoplasia.
    Ashley C; Kirkland JA; Stanley MA
    Pathology; 1974 Oct; 6(4):329-35. PubMed ID: 4615290
    [No Abstract]   [Full Text] [Related]  

  • 27. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia.
    Mendis LN; Best JM; Banatvala JE
    Int J Cancer; 1981 May; 27(5):669-77. PubMed ID: 6270022
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of herpesvirus type 2 to carcinoma of the cervix.
    Rawls WE; Kaufman RH; Gardner HL
    Clin Obstet Gynecol; 1972 Dec; 15(4):919-28. PubMed ID: 4346320
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer.
    te Velde ER; Aurelian L
    Tumour Biol; 1987; 8(1):26-33. PubMed ID: 3037680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpesvirus-induced antigens in squamous-cell carcinoma in situ of the vulva.
    Kaufman RH; Dreesman GR; Burek J; Korhonen MO; Matson DO; Melnick JL; Powell KL; Purifoy DJ; Courtney RJ; Adam E
    N Engl J Med; 1981 Aug; 305(9):483-8. PubMed ID: 6265780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Squamous cell carcinoma related antigen in uterine cervical carcinoma.
    Cheah PL; Yap SF; Looi LM; Sivanesaratnam V
    Malays J Pathol; 1991 Jun; 13(1):37-41. PubMed ID: 1795560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibodies in patients with cervicouterine carcinoma].
    Gomez-Estrada H; Huerta-Sanchez R; Hernandez-Sanchez R; Garza-Eufrasio O; Venustiano-Carranza J; Miranda-Acevedo C; Terrazas-Flores JA; Fernandez-Quintero P
    Arch Invest Med (Mex); 1975; 6(1):13-22. PubMed ID: 169759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of indirect hemagglutination test to measurement of type specific antibody to herpes simplex virus in human sera.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1979; 23(8):801-4. PubMed ID: 232237
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 36. Herpesvirus hominis: from latency to carcinogenesis?
    Aurelian L
    Johns Hopkins Med J Suppl; 1973; 2():245-66. PubMed ID: 4137697
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies demonstrating the immunological identity of the tumour-associated antigen AG-4 with a virion envelope protein.
    Strnad BC; Smith MF; Aurelian L
    IARC Sci Publ (1971); 1978; (24 Pt 1):203-13. PubMed ID: 87365
    [No Abstract]   [Full Text] [Related]  

  • 38. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
    Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
    Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoenzymatic detection of IgA and IgG antibodies to HSV-1, HSV-2 in sera of patients with cervical cancer (author's transl)].
    Fan J; Zeng Y; Liu YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Feb; 4(1):50-2. PubMed ID: 6279319
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies to herpesvirus type 2 in carcinoma of the cervix uteri in Ibadan, Nigeria.
    Adelusi B; Osunkoya BO; Fabiyi A
    Am J Obstet Gynecol; 1975 Dec; 123(7):758-61. PubMed ID: 1106197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.